期刊文献+

埃索美拉唑、左氧氟沙星、阿莫西林三联法治疗幽门螺杆菌感染疗效观察 被引量:3

Triple therapy of esomeprazole, levofloxacin and amoxicillin combined for Helicobacter Pylori eradication
下载PDF
导出
摘要 目的探讨埃索美拉唑+左氧氟沙星+阿莫西林一周疗法根除幽门螺杆菌(HP)的疗效。方法选择82例HP阳性消化性溃疡患者,随机分为两组。治疗组采用埃索美拉唑(20mg,每日2次)加左氧氟沙星(200mg,每日2次)加阿莫西林(1000mg,每日2次),治疗7天后继续用埃索美拉唑20mg,每日1次,3周。对照组采用埃索美拉唑(20mg,每日2次)加甲硝唑(400mg,每日2次),加阿莫西林(1000mg,每日2次),治疗7天后继续用埃索美拉唑20mg,每日1次,3周。疗程结束4周后复查胃镜和HP,观察HP根除率,症状缓解率、溃疡愈合率和不良反应。结果治疗组和对照组HP根除率分别为92.7%和75.6%,两组差异有显著性(P<0.05),治疗组和对照组症状缓解率、溃疡愈合率和不良反应发生率分别为95.1%和90.2%,95.1%和92.7%,22%和19.5%,两组无明显差异(P>0.05)。结论埃索美拉唑加左氧氟沙星加阿莫西林三联1周疗法是根除HP的理想方案。 Objective To study the efficacy of 1 week triple therapy of esomeprazole, levofloxaein and amoxieillin combined for Helieobaeter pylori (Hp) eradication. Methods 82 patients with Hp infection Suffering from Peptic ulcer were randomized to treatment group and control group. The treatment group were administered esomeprazole (20mg,twice a day) , levofloxaein (200mg, twice a day) and amoxieillin (1 000rag, twice a day) for 1 week . The control group were administered esomeprazole (20mg,twice a day), metronidazole (400mg, twice a day) and amoxieillin (1 000mg, twice a day) for 1 week . All patients were treated with esomeprazole (20mg,every day)for another three weeks. Four weeks later, the Hp eradication, symptoms, peptic ulcer healing and side-effects were observed. Results The Hp eradication rate between the treatment group and control group were 92.7%, 75.6%, respectively. There was significant difference between two groups (P〈0.05). The symptom ameliorate rate, puptie ulcer healing rate and side-effect rate between the treatment group and control group were 95.1% and 90.2% , 95.1% and 92.7% , 22% and 19.5% , respectively . The difference was not-significant (P〉0.05). Conclusion 1 week triple therapy of esomeprazole, levofloxaein and amoxieillin combined is the first choice for Hp eradication.
作者 龚梅金 卢卫
出处 《中国现代医药杂志》 2007年第6期52-54,共3页 Modern Medicine Journal of China
关键词 消化性溃疡 幽门螺杆菌 埃索美拉唑 左氧氟沙星 阿莫西林 Peptic ulcer Helicobactorpylori Esomeprazole Levofloxacin Amoxicillin
  • 相关文献

参考文献3

二级参考文献9

  • 1Malfertheiner P, Megraud F, O'Morain C, et al. European Helicobacter Pylori Study Group(EHPSG). Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther, 2002,16:167-180.
  • 2张林 刘文忠.铋剂在根除幽门螺杆菌治疗中的作用[A].见:刘文忠主编.幽门螺杆菌研究进展[C].上海:上海科学技术文献出版社,2001.377.
  • 3International Agency for Research on Cancer.Schistosomes,liver flukes and Helicobacter pylori.IARC Working Group on the evaluation of carcinogenic risks to humans[J].IARCMonogr Eval Carcinog Risks Hum,1994,61:177-241.
  • 4Xia HH,Talley NJ.Prospects for improved therapy for Helicobacter pylori infection[J].Exp Opin Invest Drugs,1996,5:959-976.
  • 5Bazzoli F,Zagari RM,Fossi S,et al.Short-term-low dose triple therapy for the eradication of Helicobacter pylori[J].Eur J Gastroenterol Hepatol,1994,6(8):773-777.
  • 6Savaino V,Sandro Mela G,Zentilin P,et al.Acid inhibition and amoxicillin activity against Helicobacter pylori[J].Am J Gastroenterol,1993,88(11):1975-1976.
  • 7沈兰兰.幽门螺杆菌共识 1997年亚太地区关于幽门螺杆菌感染处理的共识会议报告[J].国外医学(消化系疾病分册),1998,18(2):67-76. 被引量:22
  • 8张万岱.幽门螺杆菌若干问题的共识意见[J].中华消化杂志,2000,20(2):117-118. 被引量:387
  • 9张万岱,萧树东,胡伏莲,林三仁,胡品津,刘文忠,王继德,徐智民.幽门螺杆菌共识意见(2003·安徽桐城)[J].中华消化杂志,2004,24(2):126-127. 被引量:438

共引文献439

同被引文献28

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部